Jake Leach's Insider Trades & SAST Disclosures
Jake Leach's most recent trade in Dexcom Inc was a trade of 14,076 Common Stock done at an average price of $70.4 . Disclosure was reported to the exchange on March 12, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jake Leach.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dexcom Inc | Jake Leach | EVP, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 70.38 per share. | 12 Mar 2025 | 14,076 | 313,497 (0%) | 0% | 70.4 | 990,670 | Common Stock |
| Dexcom Inc | Jake Leach | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2025 | 35,906 | 304,775 (0%) | 0% | 0 | Common Stock | |
| Dexcom Inc | Jake Leach | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2025 | 22,798 | 327,573 (0%) | 0% | 0 | Common Stock | |
| Dexcom Inc | Jake Leach | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 7,107 | 271,278 (0%) | 0% | 0 | Common Stock | |
| Dexcom Inc | Jake Leach | EVP, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 86.91 per share. | 28 Jan 2025 | 2,634 | 268,644 (0%) | 0% | 86.9 | 228,932 | Common Stock |
| Dexcom Inc | Jake Leach | EVP, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 76.87 per share. | 16 Dec 2024 | 744 | 264,171 (0%) | 0% | 76.9 | 57,191 | Common Stock |
| Dexcom Inc | Jake Leach | EVP, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 69.15 per share. | 09 Sep 2024 | 746 | 264,915 (0%) | 0% | 69.2 | 51,586 | Common Stock |
| SenesTech Inc | Jake Leach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2024 | 23,894 | 23,894 | - | - | Stock Option (right to buy) | |
| Dexcom Inc | Jake Leach | EVP Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 115.05 per share. | 10 Jun 2024 | 745 | 265,577 (0%) | 0% | 115.1 | 85,713 | Common Stock |
| SenesTech Inc | Jake Leach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2024 | 4,469 | 4,469 | - | - | Stock Option (right to buy) | |
| Dexcom Inc | Jake Leach | EVP Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 134.41 per share. | 12 Mar 2024 | 14,639 | 273,913 (0%) | 0% | 134.4 | 1,967,638 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Operating Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Mar 2024 | 7,736 | 266,177 (0%) | 0% | 0 | Common Stock | |
| Dexcom Inc | Jake Leach | EVP Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 26,053 | 288,552 (0%) | 0% | 0 | Common Stock | |
| Dexcom Inc | Leach Jake | EVP Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 9,697 | 266,477 (0%) | 0% | 0.0 | 10 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 123.63 per share. | 12 Jan 2024 | 3,978 | 262,499 (0%) | 0% | 123.6 | 491,819 | Common Stock |
| Dexcom Inc | Leach Jake | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 121.85 per share. | 18 Dec 2023 | 2,932 | 256,780 (0%) | 0% | 121.9 | 357,266 | Common Stock |
| SenesTech Inc | Jake Leach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 41,010 | 41,010 | - | - | Stock Option (right to buy) | |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 125.00 per share. | 20 Apr 2023 | 30,764 | 259,613 (0%) | 0% | 125 | 3,845,500 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale or transfer of securities back to the company at price $ 111.40 per share. | 10 Mar 2023 | 7,986 | 294,960 (0%) | 0% | 111.4 | 889,632 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale or transfer of securities back to the company at price $ 111.40 per share. | 10 Mar 2023 | 4,583 | 290,377 (0%) | 0% | 111.4 | 510,542 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale or transfer of securities back to the company at price $ 111.40 per share. | 10 Mar 2023 | 3,540 | 302,946 (0%) | 0% | 111.4 | 394,352 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 25,397 | 306,486 (0%) | 0% | 0.0 | 25 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 114.45 per share. | 06 Mar 2023 | 10,425 | 288,808 (0%) | 0% | 114.4 | 1,193,116 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 115.13 per share. | 06 Mar 2023 | 7,719 | 281,089 (0%) | 0% | 115.1 | 888,706 | Common Stock |
| SenesTech Inc | Jake Leach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 199,071 | 199,071 | - | - | Stock Option (right to buy) | |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 6,741 | 79,019 (0%) | 0% | 0.0 | 7 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale or transfer of securities back to the company at price $ 406.06 per share. | 08 Mar 2022 | 2,065 | 75,637 (0%) | 0% | 406.1 | 838,507 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale or transfer of securities back to the company at price $ 406.06 per share. | 08 Mar 2022 | 1,317 | 77,702 (0%) | 0% | 406.1 | 534,777 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale or transfer of securities back to the company at price $ 406.06 per share. | 08 Mar 2022 | 891 | 74,746 (0%) | 0% | 406.1 | 361,797 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2021 | 2,925 | 72,247 (0%) | 0% | 0.0 | 3 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 541.36 per share. | 09 Sep 2021 | 1,248 | 69,337 (0%) | 0% | 541.4 | 675,617 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 542.00 per share. | 09 Sep 2021 | 15 | 69,322 (0%) | 0% | 542 | 8,130 | Common Stock |
| SenesTech Inc | Jake Leach | Director | Purchase of securities on an exchange or from another person at price $ 1.54 per share. | 16 Aug 2021 | 50,000 | 50,000 (0%) | 0% | 1.5 | 76,885 | Common Stock |
| SenesTech Inc | Jake Leach | Director | Purchase of securities on an exchange or from another person at price $ 1.54 per share. | 16 Aug 2021 | 50,000 | 150,000 (0%) | 0% | 1.5 | 77,095 | Common Stock |
| SenesTech Inc | Jake Leach | Director | Purchase of securities on an exchange or from another person at price $ 1.50 per share. | 16 Aug 2021 | 50,000 | 100,000 (0%) | 0% | 1.5 | 74,785 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 476.70 per share. | 30 Jul 2021 | 12,087 | 70,554 (0%) | 0% | 476.7 | 5,761,873 | Common Stock |
| SenesTech Inc | Jake Leach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 39,038 | 39,038 | - | - | Stock Option (right to buy) | |
| SenesTech Inc | Jake Leach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 33,762 | 72,800 | - | - | Stock Option (right to buy) | |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 395.00 per share. | 09 Jun 2021 | 22,755 | 82,641 (0%) | 0% | 395 | 8,988,225 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 362.92 per share. | 10 Mar 2021 | 5,353 | 105,396 (0%) | 0% | 362.9 | 1,942,695 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 7,171 | 110,749 (0%) | 0% | 0.0 | 7 | Common Stock |
| SenesTech Inc | Jake Leach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2020 | 27,046 | 27,046 | - | - | Stock Option (right to buy) | |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 398.30 per share. | 09 Sep 2020 | 2,577 | 104,831 (0%) | 0% | 398.3 | 1,026,424 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 398.30 per share. | 09 Sep 2020 | 1,283 | 103,548 (0%) | 0% | 398.3 | 511,021 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 377.98 per share. | 11 Jun 2020 | 7,466 | 109,451 (0%) | 0% | 378.0 | 2,822,016 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 376.78 per share. | 11 Jun 2020 | 3,481 | 116,917 (0%) | 0% | 376.8 | 1,311,558 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 374.30 per share. | 11 Jun 2020 | 2,600 | 122,198 (0%) | 0% | 374.3 | 973,169 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 379.42 per share. | 11 Jun 2020 | 1,982 | 107,469 (0%) | 0% | 379.4 | 752,004 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 375.68 per share. | 11 Jun 2020 | 1,800 | 120,398 (0%) | 0% | 375.7 | 676,228 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 372.97 per share. | 11 Jun 2020 | 1,700 | 124,798 (0%) | 0% | 373.0 | 634,048 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 380.06 per share. | 11 Jun 2020 | 100 | 107,369 (0%) | 0% | 380.1 | 38,006 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges